2nd Allergy Drug Discovery
31 January 2013 - 01 February 2012
The conference will bring together industry, academia and government experts in the field of allergy, asthma and COPD. Experts will facilitate discourse on the challenges and opportunities for therapeutic and drug development for allergic diseases for the current and future generations. Topics will range from basic scientific research to biomarkers and clinical development. Novel immune targets, new therapeutic interventions, genetics, epigenetics and biomarkers in allergic diseases will be presented
The Westin Gaslamp Quarter San Diego, 910 Broadway Circle, San Diego, CA 92101
http://www.gtcbio.com/index.php?option=com_conference&file=home&cn=2nd%20Allergy%20Drug%20Discovery&cid=53
Immunogenicity & Immunotoxicity
31 January 2013 - 01 February 2013
This is the West Coast's first 2 day conference that brings together leading experts in industry, academia and the FDA. The inaugural conference will provide in-depth analysis, panel discussions and speaker presentations on cutting edge research and technologies in an intimate atmosphere. In addition the conference will focus on a number of topics including Immunogenicity Prediction, Risk, Mitigation and Clinical Relevance. With Southern California home to a number of industry leaders in the field, this event promises to become a must attend conference.
The Westin Gaslamp Quarter San Diego, 910 Broadway Circle, San Diego, CA 92101
http://www.gtcbio.com/index.php?option=com_conference&file=home&cn=Immunogenicity%20&cid=109
5th Immunotherapeutics & Immunomonitoring Conference
31 January 2013 - 01 February 2013
Network with clinical immunologists, pathologists, and pharmacologists, as well as practicing clinicians and R&D scientists, to discuss the newest development in the field. Leading experts from the scientific and clinical arenas and industry will present about novel findings and developments in the constantly changing area of immunological assays and procedures. They will also discuss recent advances in immunotherapy, as they relate to various immunotherapy modalities, specific cancers, cell subsets, animal models, and tumor microenvironment. Potential clinical feasibility and commercial potential of the newest data obtained from leading biomedical research laboratories will also be discussed
The Westin Gaslamp Quarter San Diego, 910 Broadway Circle, San Diego, CA 92101
http://www.gtcbio.com/component/conference/?file=home&cn=5th+ImmunoTherapeutics+&ImmunoMonitoring=&cid=52
Biomarkers for Brain Disorders: Challenges and Opportunities
03 February 2013 - 05 February 2013
The discovery and validation of biomarkers in neurological and neurodegenerative diseases is an important challenge for early diagnosis of disease and for the development of therapeutics. Methodological and regulatory aspects of biomarker identification and qualification across a wide spectrum of neurodevelopmental, neurodegenerative and neuropsychiatric diseases will be discussed including, autism, Parkinson's disease, Alzheimer’s disease, multiple sclerosis and schizophrenia. There will also be a series of break-out sessions for in-depth discussion on the standardization of clinical biomarkers most likely to aid diagnosis and imaging-based studies in biomarker drug discovery. This meeting provides an opportunity for scientists from academia and the commercial sector to discuss the current ‘state of the art’ in biomarkers and will aid future investment decisions in both sectors.
Møller Centre, Churchill College, Cambridge, UK
https://registration.hinxton.wellcome.ac.uk/display_info.asp?id=303
3rd Cell Based Assays UK
06 February 2013 - 07 February 2013
Join us for an exciting two days of innovative and interactive discussions about the potential of CBA and what is currently on offer in the market today. This is a great opportunity to network with professionals in the field and enjoy learning about new developments in technology, methods and detection involved in the CBA process.
London UK
http://www.visiongain.com/Conference/343/3rd-Cell-Based-Assays-UK
4th Annual Drug Delivery and Formulation Summit
18 February 2013 - 20 February 2013
Discover new technologies & drug delivery platforms
The World Drug Delivery & Formulation Summit will take place in Berlin, Germany on February 2013 with the leading drug formulation and delivery professionals from across Europe to examine the latest technological developments and strategic advancements affecting the industry.
The event sources and presents leading global case studies from Pfizer, GSK, Novartis, Merck, Eli Lilly and many more. The summit is packed full of real life case studies, allowing you to benchmark your business approach & technologies against ‘best in class’ and ensure that you have the tools you need to form a coherent and logical strategy.
For more information please visit www.ddfevent.com?mc=EL
Maritim ProArte Hotel, Berlin, Germany
http://ddfevent.com/
5th International Conference on Drug Discovery and Therapy
18 February 2013 - 21 February 2013
This unique international conference provides a platform for all pharmaceutical scientists, internists and primary care physicians to discuss and learn about all the important international breakthrough developments in drug discovery and on new therapeutics.
This conference organized by Eureka Science with the support of the Higher Colleges of Technology, UAE, focuses on the interdisciplinary fields of drug discovery, drug therapy and translational medicine.
Dubai, UAE
http://icddt.com/
4th Annual World Drug Delivery & Formulation Summit 2013
18 February 2013 - 20 February 2013
The World Drug Delivery & Formulation Summit will take place in Berlin, Germany on February 2013 with the leading drug formulation and delivery professionals from across Europe to examine the latest technological developments and strategic advancements affecting the industry.
Berlin, Germany
http://www.rsc.org/ConferencesAndEvents/conference/alldetails.cfm?evid=111787
2nd BIOTECHNOLOGY WORLD CONGRESS
18 February 2013 - 21 February 2013
The conference will cover the translational nature of biotechnological research, with emphasis on both the basic science as well as its applications in industry and academia. Presentations will include latest researches, business development, strategic alliances, partnering trends, product opportunities, growth business models and strategies, licensing and pharmaceutical biotechnology (e.g. vaccines, CNS, cancer, antibodies), medical biotechnology, industrial biotechnology, bioprocess engineering, protein engineering, plant and environmental technologies, transgenic plant and crops, bioremediation, and microbial diversity research.
Dubai Women's College, Dubai, UAE
http://biotechworldcongress.com/index.php
Advances and Progress in Drug Design
18 February 2013 - 19 February 2013
SMi's 12th annual conference on Drug Design will provide attendees with a complete view of the field and will focus on GPCR and Protein-Protein Interactions, the latest insights in virtual screening and library design, as well as discussing Fragment-Based Drug Design, this informative event will bring together key opinion leaders in the field to provide attendees with an in-depth look into current advances in Drug Design.
Copthorne Tara Hotel, London, UK
http://www.smi-online.co.uk/pharmaceuticals/uk/drug-design
2nd Biotechnology World Congress
18 February 2013 - 21 February 2013
The conference will cover the translational nature of biotechnological research, with emphasis on both the basic science as well as its applications in industry and academia. Presentations will include latest researches, business development, strategic alliances, partnering trends, product opportunities, growth business models and strategies, licensing and pharmaceutical biotechnology (e.g. vaccines, CNS, cancer, antibodies), medical biotechnology, industrial biotechnology, bioprocess engineering, protein engineering, plant and environmental technologies, transgenic plant and crops, bioremediation, and microbial diversity research.
Dubai Women's College, Dubai, UAE
http://biotechworldcongress.com/generalinfo.htm
8th Annual Biomarkers Congress 2013
19 February 2013 - 20 February 2013
The 8th Annual Biomarkers Congress covers the key challenges and critical opportunities in go/no go decision making in early development and the integration of biomarkers into clinical development. Delegates will hear from the prominent decision makers in Rx/Dx co-development and personalised healthcare strategy for the oncology, respiratory and inflammation areas. Our expert speaker panel will also discuss the latest innovations in genomic and epigenetic biomarker discovery, along with the regulatory strategies needed to utilise advancing sequencing technologies within the scope of existing US and EU compliance frameworks.
Hilton Deansgate, Manchester, UK
http://www.biomarkers-congress.com/?utm_source=Etelligent&utm_medium=Email&utm_campaign=Media+partners+2013&utm_content=www%2Ebiomarkers%2Dcongress%2Ecom
3rd Ubiquitin Research and Drug Discovery
25 February 2013 - 26 February 2013
GTC’s 3rd Ubiquitin Research and Drug Discovery conference, one of three parallel tracks of the 2nd Novel Cancer Therapeutic Summit on February 25 - 26, 2013 in Las Vegas, NV, brings together a balanced mix of experts from industry, academia, biotech and government to collaborate on cutting edge research on the Ubiquitin Pathway, SUMO, Ligases and much more. This year's keynote speaker Aaron Ciechanover won the Nobel Prize for his work in Ubiquitin and two featured speakers Ray Deshaies and Rachel Klevit are recognized leaders in the field of Ubiquitin. With a number of conferences held in cities across the country this conference will be as unique as the city it is held in
Las Vegas, Nevada, USA
http://www.gtcbio.com/component/conference/?file=home&cn=3rd+Ubiquitin+Research+and+Drug+Discovery&cid=13
4th Cancer Targets and Therapeutics
25 February 2013 - 26 February 2013
With the rapid progression of molecular biology and genetics, and the subsequent emergence of many new targets, emerging targets & therapeutics provides new opportunities for the prevention and treatment of several major disease systems. The 4th Cancer Targets & Therapeutics Conference, taking place on February 25-26, 2013 in Las Vegas, NV, examines new and emerging targets and therapeutics in the area of cancer research.
Palms Casino Resort, Las Vegas, NV, USA
http://www.gtcbio.com/component/conference/?file=home&cn=4th+Cancer+Targets+and+Therapeutics&cid=60